Source: DGNews | Posted 9 years ago
US FDA Marketing Approval for Suboxone (Buprenorphine Hydrochloride/Naloxone Hydrochloride) and Subutex (Buprenorphine Hydrochloride) for Opioid Dependence
Tags:
First New Addiction Treatment Products In 30 Years Approved For In-Office Treatment
Qualified Physicians Have New Weapon to Treat Addicted Patients With Office-Based, Private Treatment Regimen
RICHMOND, VA., and LONDON, ENGLAND -- October 9, 2002 -- Reckitt Benckiser plc (RB.L) announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Suboxone
Comments